The Royal Orthopaedic Hospital, Birmingham, UK, B31 2AP.
Int Orthop. 2014 Jun;38(6):1139-45. doi: 10.1007/s00264-013-2240-7. Epub 2013 Dec 28.
Limited evidence exists regarding the outcomes of hip resurfacing in elderly patients. The primary study aims were to determine the survival and functional outcome following Birmingham Hip Resurfacing (BHR) in patients ≥65 years at up to ten years of follow-up. Secondary aims were to explore factors affecting survival and functional outcome.
Between 1997 and 2012, data were prospectively collected on 180 BHR (162 patients; mean age 69.2 years; 62 % male) implanted by one designing surgeon. Mean follow-up was six (range one to 14.4) years with no loss to follow-up. Outcomes of interest were implant survival, functional outcome [Oxford Hip Score (OHS)] and radiological evidence of implant failure.
Three hips were revised, giving an overall cumulative survival of 96.4 % [95 % confidence interval (CI) 90.3-100] at ten years. Survival of 111 male BHR was 98.9 % (95 % CI 94.8-100) at ten years (one revision) compared with 91.9 % (95 % CI 77.0-100) in 69 female BHR (two revisions). Survival was affected by age (p = 0.014) and femoral head size (p = 0.024) but not by gender (p = 0.079). Median pre-operative OHS was 50.0 % [interquartile range (IQR) 37.5-68.8], improving to 4.4 % (IQR 0-10.4) postoperatively. Men had significantly better postoperative OHSs compared with women (median male OHS 2.1 % versus 6.3 % female OHS; p = 0.021).
Good survival and functional outcomes were achieved with the BHR at ten years in men and women ≥65 years. Despite registry findings to the contrary, age alone should not be a contraindication for hip resurfacing in centres with expertise in this procedure.
有关髋关节表面置换术在老年患者中的疗效的证据有限。本研究的主要目的是确定在接受 Birmingham Hip Resurfacing(BHR)治疗的≥65 岁患者中,至随访 10 年时的生存率和功能结果。次要目的是探讨影响生存率和功能结果的因素。
1997 年至 2012 年期间,前瞻性收集了由一位设计医生植入的 180 例 BHR(162 例患者;平均年龄 69.2 岁;62%为男性)的数据。平均随访时间为 6 年(范围为 1 至 14.4 年),无失访病例。研究的重点是:植入物的生存率、功能结果[Oxford Hip Score(OHS)]和影像学上的植入物失败证据。
3 髋进行了翻修,10 年时总体累积生存率为 96.4%[95%置信区间(CI)90.3-100]。111 例男性 BHR 的 10 年生存率为 98.9%(95%CI 94.8-100)(1 例翻修),而 69 例女性 BHR 的 10 年生存率为 91.9%(95%CI 77.0-100)(2 例翻修)。生存率受年龄(p=0.014)和股骨头大小(p=0.024)的影响,但不受性别(p=0.079)的影响。术前 OHS 的中位数为 50.0%(四分位距 37.5-68.8),术后改善至 4.4%(四分位距 0-10.4)。男性术后 OHS 明显优于女性(男性 OHS 的中位数为 2.1%,女性 OHS 的中位数为 6.3%;p=0.021)。
在接受 Birmingham Hip Resurfacing(BHR)治疗的≥65 岁男性和女性中,10 年时生存率和功能结果均良好。尽管登记处的数据显示相反,但在有该手术经验的中心,年龄本身不应成为髋关节表面置换术的禁忌症。